Abstract: A biodegradable and/or bioabsorbable composite stent includes a bioabsorbable ceramic material dispersed and embedded in a biodegradable polymeric material. The bioabsorbable ceramic material is made of flakes that have a thin, flat shape. In one embodiment, the composite stent comprises a body of one or more layers of polymer alone coupled to layers of polymer in which the ceramic flakes are dispersed and embedded and the composite is coiled to form the stent.

Abstract: A bioremovable composite stent includes bioremovable polymer and bioremovable ceramic flakes generally coupled with adjacent layers of bioremovable polymer so as to make a resilient composite stent configured to move between a contracted configuration to an expanded configuration. In one embodiment, the composite stent may have a helical shape.

Abstract: A steering gear clutch includes a housing and an input shaft rotatably supported by the housing. An output shaft operatively connected with a steering gear is rotatably supported by the housing. The output shaft is rotatable relative to the input shaft. The input shaft rotates together with the output shaft relative to the housing when a torque below a predetermined value is applied to the input shaft. The input shaft rotates relative to the output shaft and the housing when a torque above the predetermined value is applied to the input shaft. The input shaft may rotate relative to a shaft portion of the output shaft and the housing through a predetermined angle. The input shaft and the shaft portion may rotate together relative to the housing when the input shaft has rotated through the predetermined angle.

Abstract: Disclosed are primers, probes, and single nucleotide polymorphisms (SNP) specific to a distinct subclones of the E. coli sequence type 131 (ST131). Also disclosed are methods and assay kits useful in detecting the presence of the distinct subtype of E. coli and methods of treating a subject suffering from an infection from a subclone of ST131.

Abstract: A steering system for turning multiple sets of steerable wheels comprises three steering gears operatively connected to the steerable wheels. Each steering gear includes a control valve assembly and has an associated hydraulic motor. The first control valve assembly directs pressurized fluid to a first hydraulic motor and also directs pressurized fluid to a second hydraulic motor. The third control valve assembly directs pressurized fluid to a third hydraulic motor. When a torque below a predetermined value is applied to an output shaft of the second steering gear, the output shaft rotates in response to movement of the first control valve assembly, and the second control valve assembly remains in a neutral condition. When a torque above the predetermined value is applied to the output shaft of the second steering gear, the output shaft rotates to cause the second control valve assembly to assume an actuated condition to direct pressurized fluid away from the second hydraulic motor.

Abstract: A steering gear clutch includes a housing and an input shaft rotatably supported by the housing. An output shaft operatively connected with a steering gear is rotatably supported by the housing. The output shaft is rotatable relative to the input shaft. The input shaft rotates together with the output shaft relative to the housing when a torque below a predetermined value is applied to the input shaft. The input shaft rotates relative to the output shaft and the housing when a torque above the predetermined value is applied to the input shaft. The input shaft may rotate relative to a shaft portion of the output shaft and the housing through a predetermined angle. The input shaft and the shaft portion may rotate together relative to the housing when the input shaft has rotated through the predetermined angle.

Abstract: The present invention provides methods and compositions for high-resolution clonal typing of Escherichia coli.

Abstract: A graphic for application to a textile is disclosed. The graphic includes a front surface configured to be viewable when the graphic is applied to the textile. The graphic further includes a back surface opposite the front surface and configured to contact the textile. The graphic further includes an attachment mechanism, other than stitching, that attaches the graphic to the textile. The graphic also includes a simulated stitching pattern “etched” onto the front surface of the graphic extending around a perimeter of the graphic and includes projections simulating stitch ends.

Abstract: Provided herein are formaldehyde-free flame retardant compositions, comprising a flame retardant acid and a fixing agent; and methods of their use for manufacturing durable formaldehyde-free flame retardant cellulosic materials. Also provided herein are durable formaldehyde-free flame retardant cellulosic materials and articles comprising the same.

Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.

Abstract: A hand held ion tester includes a housing sufficiently small to be conveniently held in a human hand. A sample chamber is formed in the housing and has a sample inlet in the upper surface of the housing. An ion selective electrode is positioned in the sample chamber so as to be in liquid communication with samples positioned in the sample chamber. A key board and a display are positioned on the upper surface of the housing and a central processing unit contained within the housing is electrically coupled to the ion selective electrode, the key board and the display. The central processing unit is designed and connected to receive signals from the ion selective electrode, process the signals and display processed information on the display.

Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.

Abstract: A control system and method of controlling a propeller aircraft engine during takeoff limits the amount of engine power developed at the very beginning of the takeoff in order to maximize thrust and minimize rollout distances. The control system limits the amount of power developed by the engine, even in the face of a nominal demand by the pilot for maximum engine power. Instead, the control system provides something significantly less than full power at the beginning of takeoff and gradually increases the power developed by the engine to full power as the airspeed increases. This gradual increase from partial engine power toward full power helps prevent stalling of the propeller, thereby maximizing the effectiveness of the propeller and engine in assisting the aircraft to takeoff quickly. The control system is particularly helpful for taking off from high-altitude runways.

Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.

Abstract: A power steering gear assembly 10 which is used to turn steerable vehicle wheels 50, 52 includes a piston 20 disposed in a motor cylinder 16. A series 44 of rack teeth are connected with the piston 20. A first tooth space 94 is formed between first and second teeth 80, 76 in the series 44 of rack teeth. The first tooth space 94 has a root portion 126 which includes first and second fillets 132, 136. The first fillet 132 has a larger radius of curvature 130 than the second fillet 136. The first and second fillets 132, 136 have centers of curvature which are both disposed between a central axis 104 of the first tooth space 94 and the second rack tooth 76. The center pinion gear tooth 190 has side surfaces 200 and 202 with intermediate portions 216 and 230 which are offset from continuously curving spatial envelopes 212 and 228 containing tip end portions 208 and 222 and root end portions 210 and 224 of the center pinion gear tooth.

Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.

Abstract: A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.

Abstract: A composite resilient scaffold may be used to grow, repair, and/or regenerate tissue such as articular cartilage. The composite scaffold is porous and at least substantially bioremovable. The composite scaffold includes a support structure coated with a discontinuous coating of separate and discrete particles of a ceramic material such as calcium phosphate. The calcium phosphate material may have a porous reticulated structure.

Abstract: A hand held ion tester includes a housing sufficiently small to be conveniently held in a human hand. A sample chamber is formed in the housing and has a sample inlet in the upper surface of the housing. An ion selective electrode is positioned in the sample chamber so as to be in liquid communication with samples positioned in the sample chamber. A key board and a display are positioned on the upper surface of the housing and a central processing unit contained within the housing is electrically coupled to the ion selective electrode, the key board and the display. The central processing unit is designed and connected to receive signals from the ion selective electrode, process the signals and display processed information on the display.

Abstract: Adherent packed beds of ceramic beads, each comprising a ceramic body coated with a biodegradable polymer, and fabric bags containing such beads in a packed, self-supporting configuration. The polymeric coating provides some resilience to a packed bed of the ceramic beads, and prevents the beads from moving with respect to each other when placed under stress, leading to reduced breakage. The ceramic beads desirably are osteoconductive, and preferably are formed of a ceramic material that is resorbed during bone growth, such as hydroxyapatite, tricalcium phosphate, or mixtures of these materials. The beads may contain, either internally or on their surfaces or both, a bone morphogenic protein, and the latter may also be included in the biodegradable polymer coatings on the beads.